Chi-Med has issued a total of 60,713,323 ordinary shares. Each Nasdaq-listed American Depositary Share (ADS) equates to half an ordinary share.
For illustrative purposes only, if converted in their entirety, this would be equivalent to 121,426,646 Nasdaq-traded ADSs.
Insofar as Chi-Med is aware, approximately 63% of the issued share capital of Chi-Med is not in public hands. Such percentage comprises the shares held by Directors and Hutchison Healthcare Holdings Limited, a significant shareholder of Chi-Med.
The tables below show major interests in shares of the Company, notified to the Company under the provisions of rule 5 of the Disclosure Rules and Transparency Rules of the U.K. Financial Conduct Authority, which have been incorporated by reference into the Company's articles of association.
Last updated: 22 March 2017
|Shareholder||Number of Ordinary|
|Approximate % of Issued Share Capital|
|Hutchison Healthcare Holdings Limited||36,666,667||60.39%|
|Mitsui & Co., Ltd.||3,214,404||5.29%|
|Slater Investments Limited||2,299,000||3.79%|
|Director||Number of Ordinary|
|Number of American Depositary Shares Held||Approximate % of Issued Share Capital|
Note: "Held" means any legal or beneficial interest held, whether directly or indirectly, on the account of the Director and such Director's "persons closely associated" (as defined in article 3 of the EU Market Abuse Regulation (No 596/2014)).